A Dose Finding Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination With Standard of Care and in Recurrent Glioblastoma as a Single Agent.

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
A Dose Finding Study of \[177Lu\]Lu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination with Standard of Care and in Recurrent Glioblastoma as a Single Agent
Epistemonikos ID: e37724da5dabf663abb45456d67619907ae72c6e
First added on: May 09, 2024